这不是前半月的事情吗_老虎社区_美港股上老虎 - 老虎社区

这不是前半月的事情吗？今天跌是因为这个？

异动解读｜Recursion Pharmaceuticals盘中下跌8.21%，合作协议调整引发市场分歧

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":615973119108176,"tweetId":"615973119108176","gmtCreate":1791403301953,"gmtModify":1791416239477,"author":{"id":3509486622393381,"idStr":"3509486622393381","authorId":3509486622393381,"authorIdStr":"3509486622393381","name":"好麻烦","avatar":"https://static.tigerbbs.com/433884406cb36de99af5c674431ac5af","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p>这不是前半月的事情吗？今天跌是因为这个？</p></body></html>","htmlText":"<html><head></head><body><p>这不是前半月的事情吗？今天跌是因为这个？</p></body></html>","text":"这不是前半月的事情吗？今天跌是因为这个？","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/615973119108176","repostId":1156567702,"repostType":2,"repost":{"id":"1156567702","kind":"news","weMediaInfo":{"introduction":"个股异动一手消息解读","home_visible":1,"media_name":"行情直击","id":"1059448697","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"pubTimestamp":1791394248,"share":"https://www.laohunote.com/m/news/1156567702?lang=zh_CN&edition=full","pubTime":"2026-10-08 01:30","market":"hk","language":"zh","title":"异动解读｜Recursion Pharmaceuticals盘中下跌8.21%，合作协议调整引发市场分歧","url":"https://stock-news.laohu8.com/highlight/detail?id=1156567702","media":"行情直击","summary":"10月8日，Recursion Pharmaceuticals盘中下跌8.21%，报4.245美元/股，成交额1.2亿美元。行业方面，生物科技板块涨跌互现，Moderna上涨1.96%，艾伯维上涨2.53%，而Twist Bioscience下跌5.16%，板块内分化明显。Recursion Pharmaceuticals是一家临床阶段的TechBio公司，通过其递归操作系统整合超过50PB的专有数据，在湿实验室实验与干实验室计算工具之间形成迭代循环，用于识别、验证和转化治疗洞见。","content":"<p><p>10月8日，Recursion Pharmaceuticals盘中下跌8.21%，报4.245美元/股，成交额1.2亿美元。</p><p>消息面上，公司与Tempus AI续签数据许可协议并新增RNA基础模型授权合作，但SEC文件显示Recursion被删除单方面终止协议的权利，同时原定两年最高8400万美元的酌情付款被替换为三年4200万美元的承诺付款，市场对合同刚性增强及短期现金流结构变化产生担忧。</p><p>行业方面，生物科技板块涨跌互现，Moderna上涨1.96%，艾伯维上涨2.53%，而Twist Bioscience下跌5.16%，板块内分化明显。</p><p>Recursion Pharmaceuticals是一家临床阶段的TechBio公司，通过其递归操作系统整合超过50PB的专有数据，在湿实验室实验与干实验室计算工具之间形成迭代循环，用于识别、验证和转化治疗洞见。</p><p>（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）</p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读｜Recursion Pharmaceuticals盘中下跌8.21%，合作协议调整引发市场分歧</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读｜Recursion Pharmaceuticals盘中下跌8.21%，合作协议调整引发市场分歧\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1059448697\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">行情直击 </p>\n<p class=\"h-time\">2026-10-08 01:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>10月8日，Recursion Pharmaceuticals盘中下跌8.21%，报4.245美元/股，成交额1.2亿美元。</p><p>消息面上，公司与Tempus AI续签数据许可协议并新增RNA基础模型授权合作，但SEC文件显示Recursion被删除单方面终止协议的权利，同时原定两年最高8400万美元的酌情付款被替换为三年4200万美元的承诺付款，市场对合同刚性增强及短期现金流结构变化产生担忧。</p><p>行业方面，生物科技板块涨跌互现，Moderna上涨1.96%，艾伯维上涨2.53%，而Twist Bioscience下跌5.16%，板块内分化明显。</p><p>Recursion Pharmaceuticals是一家临床阶段的TechBio公司，通过其递归操作系统整合超过50PB的专有数据，在湿实验室实验与干实验室计算工具之间形成迭代循环，用于识别、验证和转化治疗洞见。</p><p>（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RXRX":"Recursion Pharmaceuticals, Inc."},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156567702","content_text":"10月8日，Recursion Pharmaceuticals盘中下跌8.21%，报4.245美元/股，成交额1.2亿美元。消息面上，公司与Tempus AI续签数据许可协议并新增RNA基础模型授权合作，但SEC文件显示Recursion被删除单方面终止协议的权利，同时原定两年最高8400万美元的酌情付款被替换为三年4200万美元的承诺付款，市场对合同刚性增强及短期现金流结构变化产生担忧。行业方面，生物科技板块涨跌互现，Moderna上涨1.96%，艾伯维上涨2.53%，而Twist Bioscience下跌5.16%，板块内分化明显。Recursion Pharmaceuticals是一家临床阶段的TechBio公司，通过其递归操作系统整合超过50PB的专有数据，在湿实验室实验与干实验室计算工具之间形成迭代循环，用于识别、验证和转化治疗洞见。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","news_type":1,"symbols_score_info":{"RXRX":1}},"isVote":1,"tweetType":1,"viewCount":148,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":38,"optionInvolvedFlag":false,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/615973119108176"}